Iranian Journal of Neurology 2017. 16(2):72-77.

Modified Atkins diet in adult with refractory epilepsy: A controlled randomized clinical trial
Mohammad Zare, Ali Asghar Okhovat, Ahmad Esmaillzadeh, Jafar Mehvari, Mohammad Reza Najafi, Mohammad Saadatnia

Abstract


Background: The usefulness of the modified Atkins diet (mAD) in refractory epilepsy in adults has been rarely investigated. We aimed to evaluate the efficacy of mAD in adult with refractory epilepsy.

Methods: In a controlled randomized clinical trial, we enrolled 66 refractory adult epileptic cases from February 2010 to December 2012. The patients were randomly divided into two groups, case groups (22 patients) used antiepileptic drugs and mAD and control group (32 patients) only use antiepileptic drugs. The primary outcome was at least 50% decrement in seizure frequency after 2 months of therapy.

Results: No significant difference was shown in our data between groups regarding baseline characteristic. The differences of mean seizure attack after 2 months (P < 0.001). 6 (17.6%) had > 50% seizure decrease at 1 and after 2 months and 12 (35.3%) had 50% decrease in seizure frequency. Furthermore, in mAD group, the mean urinary ketone positivity was 1.75 ± 0.28 and increasing liver enzyme was shown 5 cases (14.7%) in mAD group and 5 cases (15.6%) in control group (P < 0.050).

Conclusion: The mAD may be effective as a cotherapy treatment for adults with refractory epilepsy and decrease 2.19 times seizure frequency in comparison with control groups. Trials with the more tolerant dietary regime, with larger sample size and longer duration, should be performed in future.

Keywords


Epilepsy; Drug Refractory; Modified Atkins Diet; Adult

Full Text:

PDF

References


Kossoff EH. More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurol 2004; 3(7): 415-20.

Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia 2008; 49(Suppl 8):37-41.

Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology 2003; 61(12): 1789-91.

Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006; 47(2): 421-4.

Kossoff EH, Turner Z, Bluml RM, PyzikPL, Vining EP. A randomized, crossovercomparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav 2007; 10(3): 432-6.

Kang HC, Lee HS, You SJ, Kang dC, Ko TS, Kim HD. Use of a modified Atkins diet in intractable childhood epilepsy. Epilepsia 2007; 48(1): 182-6.

Kossoff EH, Rowley H, Sinha SR, Vining EP. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 2008; 49(2): 316-9.

Carrette E, Vonck K, de Herdt V, Dewaele I, Raedt R, Goossens L, et al. A pilot trial with modified Atkins' diet in adult patients with refractory epilepsy.Clin Neurol Neurosurg 2008; 110(8):797-803.

Smith M, Politzer N, Macgarvie D, McAndrews MP, Del Campo M. Efficacy and tolerability of the modified Atkins diet in adults with pharmacoresistant epilepsy: a prospective observational study. Epilepsia 2011; 52(4): 775-80.

Cervenka MC, Patton K, Eloyan A, Henry B, Kossoff EH. The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr Neurosci 2016;19(3): 131-7.

Cervenka MC, Terao NN, Bosarge JL, Henry BJ, Klees AA, Morrison PF, et al.E-mail management of the modified Atkins Diet for adults with epilepsy isfeasible and effective. Epilepsia 2012;53(4): 728-32.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.